Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Interest Expense: S$-1.97 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings Interest Expense?

Singapore Institute Of Advanced Medicine Holdings SGX:9G2 -6.90% Interest Expense is S$-1.97 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Singapore Institute Of Advanced Medicine Holdings's interest expense for the three months ended in Mar. 2026 was S$ -0.88 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was S$-1.97 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Singapore Institute Of Advanced Medicine Holdings's Operating Income for the three months ended in Mar. 2026 was S$ -5.01 Mil. Singapore Institute Of Advanced Medicine Holdings's Interest Expense for the three months ended in Mar. 2026 was S$ -0.88 Mil. Singapore Institute Of Advanced Medicine Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Singapore Institute Of Advanced Medicine Holdings's Interest Expense for the three months ended in Mar. 2026 was S$-0.88 Mil. Its Operating Income for the three months ended in Mar. 2026 was S$-5.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was S$39.94 Mil.

Singapore Institute Of Advanced Medicine Holdings's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Singapore Institute Of Advanced Medicine Holdings did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Singapore Institute Of Advanced Medicine Holdings Interest Expense Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings Interest Expense Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Interest Expense
-1.19 -1.20 -2.42 -11.55 -3.17

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only 0.00 -0.73 -1.09 0.00 -0.88

Singapore Institute Of Advanced Medicine Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$-1.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of S$-1.97 Mil mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Interest Expense of S$-1.97 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors.
Is Singapore Institute Of Advanced Medicine Holdings' Interest Expense too high?
Singapore Institute Of Advanced Medicine Holdings' current Interest Expense is S$-1.97 Mil.
How does Singapore Institute Of Advanced Medicine Holdings' Interest Expense compare to HCA and THC?
Singapore Institute Of Advanced Medicine Holdings' Interest Expense of S$-1.97 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. Singapore Institute Of Advanced Medicine Holdings's current Interest Expense is S$-1.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Interest Expense of S$-1.97 Mil. The current Interest Expense is S$-1.97 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Interest Expense is S$-1.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.